nodes	percent_of_prediction	percent_of_DWPC	metapath
Dihydroergotamine—ABCB1—Dactinomycin—germ cell cancer	0.0799	0.219	CbGbCtD
Dihydroergotamine—CYP3A4—Ifosfamide—germ cell cancer	0.0566	0.155	CbGbCtD
Dihydroergotamine—ABCB1—Vinblastine—germ cell cancer	0.0501	0.137	CbGbCtD
Dihydroergotamine—ABCB1—Cisplatin—germ cell cancer	0.0459	0.126	CbGbCtD
Dihydroergotamine—ABCB1—Etoposide—germ cell cancer	0.0451	0.124	CbGbCtD
Dihydroergotamine—HTR1D—meninx—germ cell cancer	0.0372	0.111	CbGeAlD
Dihydroergotamine—HTR1B—dura mater—germ cell cancer	0.0353	0.105	CbGeAlD
Dihydroergotamine—HTR1D—dura mater—germ cell cancer	0.0342	0.102	CbGeAlD
Dihydroergotamine—HTR2B—cardial valve—germ cell cancer	0.0336	0.0998	CbGeAlD
Dihydroergotamine—CYP3A4—Vinblastine—germ cell cancer	0.03	0.0823	CbGbCtD
Dihydroergotamine—ABCB1—Methotrexate—germ cell cancer	0.0298	0.0818	CbGbCtD
Dihydroergotamine—CYP3A4—Etoposide—germ cell cancer	0.027	0.0742	CbGbCtD
Dihydroergotamine—HTR1B—trigeminal nerve—germ cell cancer	0.0152	0.0452	CbGeAlD
Dihydroergotamine—HTR1D—trigeminal nerve—germ cell cancer	0.0147	0.0437	CbGeAlD
Dihydroergotamine—HTR1B—cranial nerve—germ cell cancer	0.0108	0.0322	CbGeAlD
Dihydroergotamine—HTR1D—cranial nerve—germ cell cancer	0.0105	0.0312	CbGeAlD
Dihydroergotamine—HTR6—ganglion—germ cell cancer	0.00909	0.027	CbGeAlD
Dihydroergotamine—HTR1B—telencephalic ventricle—germ cell cancer	0.0088	0.0262	CbGeAlD
Dihydroergotamine—HTR1D—telencephalic ventricle—germ cell cancer	0.00852	0.0253	CbGeAlD
Dihydroergotamine—HTR1A—telencephalic ventricle—germ cell cancer	0.0071	0.0211	CbGeAlD
Dihydroergotamine—HTR1B—ganglion—germ cell cancer	0.00548	0.0163	CbGeAlD
Dihydroergotamine—HTR1D—ganglion—germ cell cancer	0.0053	0.0158	CbGeAlD
Dihydroergotamine—HTR1A—ganglion—germ cell cancer	0.00442	0.0131	CbGeAlD
Dihydroergotamine—HTR1B—blood vessel—germ cell cancer	0.00436	0.013	CbGeAlD
Dihydroergotamine—HTR1D—blood vessel—germ cell cancer	0.00422	0.0125	CbGeAlD
Dihydroergotamine—CYP3A4—urine—germ cell cancer	0.00358	0.0106	CbGeAlD
Dihydroergotamine—HTR6—telencephalon—germ cell cancer	0.00351	0.0104	CbGeAlD
Dihydroergotamine—HTR1B—trigeminal ganglion—germ cell cancer	0.00269	0.008	CbGeAlD
Dihydroergotamine—HTR1D—trigeminal ganglion—germ cell cancer	0.0026	0.00775	CbGeAlD
Dihydroergotamine—HTR1B—brainstem—germ cell cancer	0.00238	0.00708	CbGeAlD
Dihydroergotamine—HTR1D—brainstem—germ cell cancer	0.0023	0.00686	CbGeAlD
Dihydroergotamine—HTR1D—eye—germ cell cancer	0.00224	0.00668	CbGeAlD
Dihydroergotamine—HTR6—head—germ cell cancer	0.00218	0.00649	CbGeAlD
Dihydroergotamine—HTR1B—telencephalon—germ cell cancer	0.00211	0.00629	CbGeAlD
Dihydroergotamine—HTR1D—telencephalon—germ cell cancer	0.00205	0.00609	CbGeAlD
Dihydroergotamine—HTR1A—brainstem—germ cell cancer	0.00192	0.00572	CbGeAlD
Dihydroergotamine—HTR2B—telencephalon—germ cell cancer	0.0019	0.00566	CbGeAlD
Dihydroergotamine—Bronchospasm—Bleomycin—germ cell cancer	0.00183	0.0061	CcSEcCtD
Dihydroergotamine—HTR2B—skin of body—germ cell cancer	0.00182	0.0054	CbGeAlD
Dihydroergotamine—HTR2B—decidua—germ cell cancer	0.0018	0.00537	CbGeAlD
Dihydroergotamine—Hypoaesthesia—Vinblastine—germ cell cancer	0.00175	0.00585	CcSEcCtD
Dihydroergotamine—Pharyngitis—Vinblastine—germ cell cancer	0.00175	0.00583	CcSEcCtD
Dihydroergotamine—Dysphagia—Dactinomycin—germ cell cancer	0.00173	0.00578	CcSEcCtD
Dihydroergotamine—HTR1A—telencephalon—germ cell cancer	0.00171	0.00507	CbGeAlD
Dihydroergotamine—Swelling—Etoposide—germ cell cancer	0.00164	0.00549	CcSEcCtD
Dihydroergotamine—Acute coronary syndrome—Bleomycin—germ cell cancer	0.00163	0.00545	CcSEcCtD
Dihydroergotamine—Myocardial infarction—Bleomycin—germ cell cancer	0.00162	0.00542	CcSEcCtD
Dihydroergotamine—Cerebrovascular accident—Cisplatin—germ cell cancer	0.00162	0.00539	CcSEcCtD
Dihydroergotamine—Stupor—Methotrexate—germ cell cancer	0.0016	0.00535	CcSEcCtD
Dihydroergotamine—HTR6—brain—germ cell cancer	0.00158	0.00471	CbGeAlD
Dihydroergotamine—HTR2B—uterus—germ cell cancer	0.00158	0.00469	CbGeAlD
Dihydroergotamine—Bronchospasm—Ifosfamide—germ cell cancer	0.00156	0.00521	CcSEcCtD
Dihydroergotamine—Angina pectoris—Ifosfamide—germ cell cancer	0.00155	0.00516	CcSEcCtD
Dihydroergotamine—Face oedema—Cisplatin—germ cell cancer	0.00153	0.0051	CcSEcCtD
Dihydroergotamine—ADRA2A—trigeminal ganglion—germ cell cancer	0.00152	0.00453	CbGeAlD
Dihydroergotamine—HTR1B—midbrain—germ cell cancer	0.00152	0.00451	CbGeAlD
Dihydroergotamine—HTR1B—spinal cord—germ cell cancer	0.00148	0.0044	CbGeAlD
Dihydroergotamine—Hypoaesthesia—Bleomycin—germ cell cancer	0.00148	0.00494	CcSEcCtD
Dihydroergotamine—HTR1D—midbrain—germ cell cancer	0.00147	0.00437	CbGeAlD
Dihydroergotamine—Pollakiuria—Ifosfamide—germ cell cancer	0.00147	0.00489	CcSEcCtD
Dihydroergotamine—Petechiae—Methotrexate—germ cell cancer	0.00145	0.00486	CcSEcCtD
Dihydroergotamine—Cramp muscle—Cisplatin—germ cell cancer	0.00143	0.00476	CcSEcCtD
Dihydroergotamine—Ill-defined disorder—Vinblastine—germ cell cancer	0.00142	0.00474	CcSEcCtD
Dihydroergotamine—Acute coronary syndrome—Ifosfamide—germ cell cancer	0.00139	0.00466	CcSEcCtD
Dihydroergotamine—Speech disorder—Methotrexate—germ cell cancer	0.00139	0.00464	CcSEcCtD
Dihydroergotamine—Myocardial infarction—Ifosfamide—germ cell cancer	0.00139	0.00463	CcSEcCtD
Dihydroergotamine—HTR2B—adrenal gland—germ cell cancer	0.00138	0.00412	CbGeAlD
Dihydroergotamine—Malaise—Vinblastine—germ cell cancer	0.00138	0.00461	CcSEcCtD
Dihydroergotamine—Flushing—Bleomycin—germ cell cancer	0.00138	0.0046	CcSEcCtD
Dihydroergotamine—Vertigo—Vinblastine—germ cell cancer	0.00138	0.00459	CcSEcCtD
Dihydroergotamine—Pharyngitis—Dactinomycin—germ cell cancer	0.00138	0.00459	CcSEcCtD
Dihydroergotamine—Conjunctivitis—Ifosfamide—germ cell cancer	0.00138	0.00459	CcSEcCtD
Dihydroergotamine—ABCB1—blood vessel—germ cell cancer	0.00137	0.00408	CbGeAlD
Dihydroergotamine—Musculoskeletal stiffness—Methotrexate—germ cell cancer	0.00133	0.00445	CcSEcCtD
Dihydroergotamine—Chills—Bleomycin—germ cell cancer	0.00133	0.00445	CcSEcCtD
Dihydroergotamine—HTR1B—endocrine gland—germ cell cancer	0.00133	0.00396	CbGeAlD
Dihydroergotamine—Sweating increased—Cisplatin—germ cell cancer	0.00133	0.00445	CcSEcCtD
Dihydroergotamine—Hypertension—Vinblastine—germ cell cancer	0.00132	0.00442	CcSEcCtD
Dihydroergotamine—HTR1B—head—germ cell cancer	0.00132	0.00391	CbGeAlD
Dihydroergotamine—Cramp muscle—Etoposide—germ cell cancer	0.00131	0.00436	CcSEcCtD
Dihydroergotamine—Herpes simplex—Methotrexate—germ cell cancer	0.0013	0.00433	CcSEcCtD
Dihydroergotamine—Discomfort—Vinblastine—germ cell cancer	0.00129	0.0043	CcSEcCtD
Dihydroergotamine—Flushing—Dactinomycin—germ cell cancer	0.00129	0.00429	CcSEcCtD
Dihydroergotamine—HTR1D—head—germ cell cancer	0.00127	0.00379	CbGeAlD
Dihydroergotamine—Dysphagia—Etoposide—germ cell cancer	0.00125	0.00418	CcSEcCtD
Dihydroergotamine—Chills—Dactinomycin—germ cell cancer	0.00124	0.00415	CcSEcCtD
Dihydroergotamine—HTR1A—adrenal gland—germ cell cancer	0.00124	0.00369	CbGeAlD
Dihydroergotamine—Bronchospasm—Etoposide—germ cell cancer	0.00123	0.00412	CcSEcCtD
Dihydroergotamine—HTR1A—midbrain—germ cell cancer	0.00122	0.00364	CbGeAlD
Dihydroergotamine—Visual impairment—Ifosfamide—germ cell cancer	0.00122	0.00409	CcSEcCtD
Dihydroergotamine—Sweating increased—Etoposide—germ cell cancer	0.00122	0.00408	CcSEcCtD
Dihydroergotamine—Acute coronary syndrome—Cisplatin—germ cell cancer	0.0012	0.00401	CcSEcCtD
Dihydroergotamine—Ill-defined disorder—Bleomycin—germ cell cancer	0.0012	0.00401	CcSEcCtD
Dihydroergotamine—Vaginal inflammation—Methotrexate—germ cell cancer	0.0012	0.00399	CcSEcCtD
Dihydroergotamine—Myocardial infarction—Cisplatin—germ cell cancer	0.0012	0.00399	CcSEcCtD
Dihydroergotamine—ADRA2A—telencephalon—germ cell cancer	0.0012	0.00356	CbGeAlD
Dihydroergotamine—HTR1A—spinal cord—germ cell cancer	0.00119	0.00355	CbGeAlD
Dihydroergotamine—Anorexia—Vinblastine—germ cell cancer	0.00119	0.00398	CcSEcCtD
Dihydroergotamine—Conjunctivitis—Cisplatin—germ cell cancer	0.00119	0.00396	CcSEcCtD
Dihydroergotamine—HTR2B—head—germ cell cancer	0.00118	0.00353	CbGeAlD
Dihydroergotamine—Tinnitus—Ifosfamide—germ cell cancer	0.00118	0.00395	CcSEcCtD
Dihydroergotamine—Flushing—Ifosfamide—germ cell cancer	0.00118	0.00394	CcSEcCtD
Dihydroergotamine—Cystitis noninfective—Methotrexate—germ cell cancer	0.00117	0.0039	CcSEcCtD
Dihydroergotamine—Malaise—Bleomycin—germ cell cancer	0.00117	0.00389	CcSEcCtD
Dihydroergotamine—Cystitis—Methotrexate—germ cell cancer	0.00116	0.00386	CcSEcCtD
Dihydroergotamine—Depressed level of consciousness—Methotrexate—germ cell cancer	0.00116	0.00386	CcSEcCtD
Dihydroergotamine—Chills—Ifosfamide—germ cell cancer	0.00114	0.0038	CcSEcCtD
Dihydroergotamine—ADRA2A—decidua—germ cell cancer	0.00113	0.00337	CbGeAlD
Dihydroergotamine—Vaginal infection—Methotrexate—germ cell cancer	0.00113	0.00377	CcSEcCtD
Dihydroergotamine—Paraesthesia—Vinblastine—germ cell cancer	0.00112	0.00375	CcSEcCtD
Dihydroergotamine—Ill-defined disorder—Dactinomycin—germ cell cancer	0.00112	0.00374	CcSEcCtD
Dihydroergotamine—Acute coronary syndrome—Etoposide—germ cell cancer	0.0011	0.00368	CcSEcCtD
Dihydroergotamine—Myalgia—Bleomycin—germ cell cancer	0.0011	0.00368	CcSEcCtD
Dihydroergotamine—Myocardial infarction—Etoposide—germ cell cancer	0.0011	0.00366	CcSEcCtD
Dihydroergotamine—Discomfort—Bleomycin—germ cell cancer	0.00109	0.00363	CcSEcCtD
Dihydroergotamine—Malaise—Dactinomycin—germ cell cancer	0.00109	0.00363	CcSEcCtD
Dihydroergotamine—Decreased appetite—Vinblastine—germ cell cancer	0.00109	0.00363	CcSEcCtD
Dihydroergotamine—Bladder pain—Methotrexate—germ cell cancer	0.00108	0.00361	CcSEcCtD
Dihydroergotamine—HTR1A—endocrine gland—germ cell cancer	0.00108	0.0032	CbGeAlD
Dihydroergotamine—Pain—Vinblastine—germ cell cancer	0.00107	0.00357	CcSEcCtD
Dihydroergotamine—Confusional state—Bleomycin—germ cell cancer	0.00106	0.00355	CcSEcCtD
Dihydroergotamine—HTR1A—head—germ cell cancer	0.00106	0.00316	CbGeAlD
Dihydroergotamine—Oedema—Bleomycin—germ cell cancer	0.00106	0.00352	CcSEcCtD
Dihydroergotamine—Visual impairment—Cisplatin—germ cell cancer	0.00106	0.00352	CcSEcCtD
Dihydroergotamine—Feeling abnormal—Vinblastine—germ cell cancer	0.00103	0.00344	CcSEcCtD
Dihydroergotamine—Myalgia—Dactinomycin—germ cell cancer	0.00103	0.00343	CcSEcCtD
Dihydroergotamine—Ill-defined disorder—Ifosfamide—germ cell cancer	0.00103	0.00342	CcSEcCtD
Dihydroergotamine—Gastrointestinal pain—Vinblastine—germ cell cancer	0.00102	0.00341	CcSEcCtD
Dihydroergotamine—Tinnitus—Cisplatin—germ cell cancer	0.00102	0.00341	CcSEcCtD
Dihydroergotamine—Flushing—Cisplatin—germ cell cancer	0.00102	0.00339	CcSEcCtD
Dihydroergotamine—Agitation—Ifosfamide—germ cell cancer	0.00102	0.00339	CcSEcCtD
Dihydroergotamine—Discomfort—Dactinomycin—germ cell cancer	0.00101	0.00339	CcSEcCtD
Dihydroergotamine—Anorexia—Bleomycin—germ cell cancer	0.00101	0.00336	CcSEcCtD
Dihydroergotamine—Hypoaesthesia—Etoposide—germ cell cancer	0.000998	0.00333	CcSEcCtD
Dihydroergotamine—ADRA2A—gonad—germ cell cancer	0.000997	0.00297	CbGeAlD
Dihydroergotamine—Malaise—Ifosfamide—germ cell cancer	0.000997	0.00333	CcSEcCtD
Dihydroergotamine—Vertigo—Ifosfamide—germ cell cancer	0.000993	0.00332	CcSEcCtD
Dihydroergotamine—ADRA2A—uterus—germ cell cancer	0.000991	0.00295	CbGeAlD
Dihydroergotamine—Abdominal pain—Vinblastine—germ cell cancer	0.000988	0.0033	CcSEcCtD
Dihydroergotamine—Hypotension—Bleomycin—germ cell cancer	0.000987	0.00329	CcSEcCtD
Dihydroergotamine—Oedema—Dactinomycin—germ cell cancer	0.000985	0.00329	CcSEcCtD
Dihydroergotamine—Palpitations—Ifosfamide—germ cell cancer	0.000977	0.00326	CcSEcCtD
Dihydroergotamine—ADRA2A—pituitary gland—germ cell cancer	0.000973	0.00289	CbGeAlD
Dihydroergotamine—Musculoskeletal discomfort—Bleomycin—germ cell cancer	0.000962	0.00321	CcSEcCtD
Dihydroergotamine—Hypertension—Ifosfamide—germ cell cancer	0.000955	0.00319	CcSEcCtD
Dihydroergotamine—HTR1B—brain—germ cell cancer	0.000953	0.00284	CbGeAlD
Dihydroergotamine—Paraesthesia—Bleomycin—germ cell cancer	0.000948	0.00317	CcSEcCtD
Dihydroergotamine—HTR1A—cerebellum—germ cell cancer	0.000947	0.00282	CbGeAlD
Dihydroergotamine—Dyspnoea—Bleomycin—germ cell cancer	0.000941	0.00314	CcSEcCtD
Dihydroergotamine—Arthralgia—Ifosfamide—germ cell cancer	0.000941	0.00314	CcSEcCtD
Dihydroergotamine—Myalgia—Ifosfamide—germ cell cancer	0.000941	0.00314	CcSEcCtD
Dihydroergotamine—ADRA2A—medulla oblongata—germ cell cancer	0.000939	0.00279	CbGeAlD
Dihydroergotamine—Anorexia—Dactinomycin—germ cell cancer	0.000939	0.00313	CcSEcCtD
Dihydroergotamine—Flushing—Etoposide—germ cell cancer	0.000931	0.00311	CcSEcCtD
Dihydroergotamine—Discomfort—Ifosfamide—germ cell cancer	0.00093	0.0031	CcSEcCtD
Dihydroergotamine—HTR1D—brain—germ cell cancer	0.000923	0.00275	CbGeAlD
Dihydroergotamine—Hypersensitivity—Vinblastine—germ cell cancer	0.000921	0.00307	CcSEcCtD
Dihydroergotamine—Decreased appetite—Bleomycin—germ cell cancer	0.000918	0.00306	CcSEcCtD
Dihydroergotamine—Muscle spasms—Cisplatin—germ cell cancer	0.000916	0.00306	CcSEcCtD
Dihydroergotamine—Confusional state—Ifosfamide—germ cell cancer	0.00091	0.00304	CcSEcCtD
Dihydroergotamine—Pain—Bleomycin—germ cell cancer	0.000903	0.00301	CcSEcCtD
Dihydroergotamine—Oedema—Ifosfamide—germ cell cancer	0.000902	0.00301	CcSEcCtD
Dihydroergotamine—Chills—Etoposide—germ cell cancer	0.0009	0.003	CcSEcCtD
Dihydroergotamine—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.000897	0.003	CcSEcCtD
Dihydroergotamine—Asthenia—Vinblastine—germ cell cancer	0.000897	0.00299	CcSEcCtD
Dihydroergotamine—Tremor—Cisplatin—germ cell cancer	0.000893	0.00298	CcSEcCtD
Dihydroergotamine—Cerebrovascular accident—Methotrexate—germ cell cancer	0.000886	0.00296	CcSEcCtD
Dihydroergotamine—Ill-defined disorder—Cisplatin—germ cell cancer	0.000884	0.00295	CcSEcCtD
Dihydroergotamine—Hyperhidrosis—Ifosfamide—germ cell cancer	0.000872	0.00291	CcSEcCtD
Dihydroergotamine—Feeling abnormal—Bleomycin—germ cell cancer	0.00087	0.0029	CcSEcCtD
Dihydroergotamine—ADRA2A—adrenal gland—germ cell cancer	0.000869	0.00259	CbGeAlD
Dihydroergotamine—Anorexia—Ifosfamide—germ cell cancer	0.00086	0.00287	CcSEcCtD
Dihydroergotamine—Malaise—Cisplatin—germ cell cancer	0.00086	0.00287	CcSEcCtD
Dihydroergotamine—HTR2B—brain—germ cell cancer	0.000859	0.00255	CbGeAlD
Dihydroergotamine—ADRA2A—midbrain—germ cell cancer	0.000858	0.00255	CbGeAlD
Dihydroergotamine—Decreased appetite—Dactinomycin—germ cell cancer	0.000856	0.00286	CcSEcCtD
Dihydroergotamine—Diarrhoea—Vinblastine—germ cell cancer	0.000855	0.00286	CcSEcCtD
Dihydroergotamine—Fatigue—Dactinomycin—germ cell cancer	0.000849	0.00283	CcSEcCtD
Dihydroergotamine—ABCB1—trigeminal ganglion—germ cell cancer	0.000848	0.00252	CbGeAlD
Dihydroergotamine—Hypotension—Ifosfamide—germ cell cancer	0.000843	0.00282	CcSEcCtD
Dihydroergotamine—Pain—Dactinomycin—germ cell cancer	0.000842	0.00281	CcSEcCtD
Dihydroergotamine—Muscle spasms—Etoposide—germ cell cancer	0.00084	0.0028	CcSEcCtD
Dihydroergotamine—Urticaria—Bleomycin—germ cell cancer	0.000839	0.0028	CcSEcCtD
Dihydroergotamine—ADRA2A—spinal cord—germ cell cancer	0.000837	0.00249	CbGeAlD
Dihydroergotamine—Body temperature increased—Bleomycin—germ cell cancer	0.000835	0.00279	CcSEcCtD
Dihydroergotamine—HTR2B—lymph node—germ cell cancer	0.00083	0.00247	CbGeAlD
Dihydroergotamine—Dizziness—Vinblastine—germ cell cancer	0.000827	0.00276	CcSEcCtD
Dihydroergotamine—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	0.000822	0.00274	CcSEcCtD
Dihydroergotamine—ABCB1—embryo—germ cell cancer	0.000819	0.00244	CbGeAlD
Dihydroergotamine—Myalgia—Cisplatin—germ cell cancer	0.000811	0.00271	CcSEcCtD
Dihydroergotamine—Feeling abnormal—Dactinomycin—germ cell cancer	0.000811	0.00271	CcSEcCtD
Dihydroergotamine—ADRA2A—female gonad—germ cell cancer	0.000811	0.00241	CbGeAlD
Dihydroergotamine—Paraesthesia—Ifosfamide—germ cell cancer	0.00081	0.00271	CcSEcCtD
Dihydroergotamine—Ill-defined disorder—Etoposide—germ cell cancer	0.00081	0.00271	CcSEcCtD
Dihydroergotamine—Anxiety—Cisplatin—germ cell cancer	0.000809	0.0027	CcSEcCtD
Dihydroergotamine—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.000805	0.00269	CcSEcCtD
Dihydroergotamine—Dyspnoea—Ifosfamide—germ cell cancer	0.000804	0.00269	CcSEcCtD
Dihydroergotamine—Somnolence—Ifosfamide—germ cell cancer	0.000802	0.00268	CcSEcCtD
Dihydroergotamine—Discomfort—Cisplatin—germ cell cancer	0.000802	0.00268	CcSEcCtD
Dihydroergotamine—Vomiting—Vinblastine—germ cell cancer	0.000795	0.00265	CcSEcCtD
Dihydroergotamine—Malaise—Etoposide—germ cell cancer	0.000787	0.00263	CcSEcCtD
Dihydroergotamine—Vertigo—Etoposide—germ cell cancer	0.000785	0.00262	CcSEcCtD
Dihydroergotamine—Decreased appetite—Ifosfamide—germ cell cancer	0.000784	0.00262	CcSEcCtD
Dihydroergotamine—Headache—Vinblastine—germ cell cancer	0.000783	0.00261	CcSEcCtD
Dihydroergotamine—Body temperature increased—Dactinomycin—germ cell cancer	0.000778	0.0026	CcSEcCtD
Dihydroergotamine—Abdominal pain—Dactinomycin—germ cell cancer	0.000778	0.0026	CcSEcCtD
Dihydroergotamine—Fatigue—Ifosfamide—germ cell cancer	0.000778	0.0026	CcSEcCtD
Dihydroergotamine—Oedema—Cisplatin—germ cell cancer	0.000778	0.0026	CcSEcCtD
Dihydroergotamine—Hypersensitivity—Bleomycin—germ cell cancer	0.000778	0.0026	CcSEcCtD
Dihydroergotamine—Pain—Ifosfamide—germ cell cancer	0.000772	0.00258	CcSEcCtD
Dihydroergotamine—HTR1A—brain—germ cell cancer	0.000769	0.00229	CbGeAlD
Dihydroergotamine—Tachycardia—Cisplatin—germ cell cancer	0.000759	0.00253	CcSEcCtD
Dihydroergotamine—Asthenia—Bleomycin—germ cell cancer	0.000758	0.00253	CcSEcCtD
Dihydroergotamine—Hypertension—Etoposide—germ cell cancer	0.000754	0.00252	CcSEcCtD
Dihydroergotamine—ADRA2A—endocrine gland—germ cell cancer	0.000754	0.00224	CbGeAlD
Dihydroergotamine—Hyperhidrosis—Cisplatin—germ cell cancer	0.000752	0.00251	CcSEcCtD
Dihydroergotamine—Pruritus—Bleomycin—germ cell cancer	0.000747	0.00249	CcSEcCtD
Dihydroergotamine—ADRA2A—head—germ cell cancer	0.000744	0.00221	CbGeAlD
Dihydroergotamine—Feeling abnormal—Ifosfamide—germ cell cancer	0.000744	0.00248	CcSEcCtD
Dihydroergotamine—Nausea—Vinblastine—germ cell cancer	0.000743	0.00248	CcSEcCtD
Dihydroergotamine—Anorexia—Cisplatin—germ cell cancer	0.000742	0.00248	CcSEcCtD
Dihydroergotamine—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.000738	0.00246	CcSEcCtD
Dihydroergotamine—Discomfort—Etoposide—germ cell cancer	0.000735	0.00245	CcSEcCtD
Dihydroergotamine—Hypotension—Cisplatin—germ cell cancer	0.000727	0.00243	CcSEcCtD
Dihydroergotamine—Hypersensitivity—Dactinomycin—germ cell cancer	0.000725	0.00242	CcSEcCtD
Dihydroergotamine—ABCB1—retina—germ cell cancer	0.000724	0.00215	CbGeAlD
Dihydroergotamine—ADRA2A—testis—germ cell cancer	0.000719	0.00214	CbGeAlD
Dihydroergotamine—Confusional state—Etoposide—germ cell cancer	0.000719	0.0024	CcSEcCtD
Dihydroergotamine—Urticaria—Ifosfamide—germ cell cancer	0.000717	0.00239	CcSEcCtD
Dihydroergotamine—Abdominal pain—Ifosfamide—germ cell cancer	0.000713	0.00238	CcSEcCtD
Dihydroergotamine—Body temperature increased—Ifosfamide—germ cell cancer	0.000713	0.00238	CcSEcCtD
Dihydroergotamine—Musculoskeletal discomfort—Cisplatin—germ cell cancer	0.000709	0.00237	CcSEcCtD
Dihydroergotamine—Asthenia—Dactinomycin—germ cell cancer	0.000706	0.00236	CcSEcCtD
Dihydroergotamine—Paraesthesia—Cisplatin—germ cell cancer	0.000699	0.00233	CcSEcCtD
Dihydroergotamine—Upper respiratory tract infection—Methotrexate—germ cell cancer	0.000698	0.00233	CcSEcCtD
Dihydroergotamine—Tachycardia—Etoposide—germ cell cancer	0.000696	0.00232	CcSEcCtD
Dihydroergotamine—Dyspnoea—Cisplatin—germ cell cancer	0.000694	0.00232	CcSEcCtD
Dihydroergotamine—Hyperhidrosis—Etoposide—germ cell cancer	0.000689	0.0023	CcSEcCtD
Dihydroergotamine—Anorexia—Etoposide—germ cell cancer	0.000679	0.00227	CcSEcCtD
Dihydroergotamine—Decreased appetite—Cisplatin—germ cell cancer	0.000676	0.00226	CcSEcCtD
Dihydroergotamine—Diarrhoea—Dactinomycin—germ cell cancer	0.000674	0.00225	CcSEcCtD
Dihydroergotamine—Vomiting—Bleomycin—germ cell cancer	0.000671	0.00224	CcSEcCtD
Dihydroergotamine—Hypotension—Etoposide—germ cell cancer	0.000666	0.00222	CcSEcCtD
Dihydroergotamine—ABCB1—telencephalon—germ cell cancer	0.000666	0.00198	CbGeAlD
Dihydroergotamine—Rash—Bleomycin—germ cell cancer	0.000666	0.00222	CcSEcCtD
Dihydroergotamine—Pain—Cisplatin—germ cell cancer	0.000665	0.00222	CcSEcCtD
Dihydroergotamine—Dermatitis—Bleomycin—germ cell cancer	0.000665	0.00222	CcSEcCtD
Dihydroergotamine—Hypersensitivity—Ifosfamide—germ cell cancer	0.000665	0.00222	CcSEcCtD
Dihydroergotamine—ADRA2A—cerebellum—germ cell cancer	0.000664	0.00198	CbGeAlD
Dihydroergotamine—Conjunctivitis—Methotrexate—germ cell cancer	0.000651	0.00217	CcSEcCtD
Dihydroergotamine—Asthenia—Ifosfamide—germ cell cancer	0.000647	0.00216	CcSEcCtD
Dihydroergotamine—Feeling abnormal—Cisplatin—germ cell cancer	0.000641	0.00214	CcSEcCtD
Dihydroergotamine—Paraesthesia—Etoposide—germ cell cancer	0.00064	0.00214	CcSEcCtD
Dihydroergotamine—Pruritus—Ifosfamide—germ cell cancer	0.000638	0.00213	CcSEcCtD
Dihydroergotamine—Dyspnoea—Etoposide—germ cell cancer	0.000635	0.00212	CcSEcCtD
Dihydroergotamine—Somnolence—Etoposide—germ cell cancer	0.000634	0.00212	CcSEcCtD
Dihydroergotamine—Epistaxis—Methotrexate—germ cell cancer	0.000631	0.00211	CcSEcCtD
Dihydroergotamine—ABCB1—decidua—germ cell cancer	0.000631	0.00188	CbGeAlD
Dihydroergotamine—Nausea—Bleomycin—germ cell cancer	0.000627	0.00209	CcSEcCtD
Dihydroergotamine—Vomiting—Dactinomycin—germ cell cancer	0.000626	0.00209	CcSEcCtD
Dihydroergotamine—Rash—Dactinomycin—germ cell cancer	0.000621	0.00207	CcSEcCtD
Dihydroergotamine—Decreased appetite—Etoposide—germ cell cancer	0.00062	0.00207	CcSEcCtD
Dihydroergotamine—Diarrhoea—Ifosfamide—germ cell cancer	0.000617	0.00206	CcSEcCtD
Dihydroergotamine—Body temperature increased—Cisplatin—germ cell cancer	0.000615	0.00205	CcSEcCtD
Dihydroergotamine—Fatigue—Etoposide—germ cell cancer	0.000614	0.00205	CcSEcCtD
Dihydroergotamine—Pain—Etoposide—germ cell cancer	0.000609	0.00203	CcSEcCtD
Dihydroergotamine—Dizziness—Ifosfamide—germ cell cancer	0.000597	0.00199	CcSEcCtD
Dihydroergotamine—Pharyngitis—Methotrexate—germ cell cancer	0.000596	0.00199	CcSEcCtD
Dihydroergotamine—CYP3A4—endocrine gland—germ cell cancer	0.000593	0.00177	CbGeAlD
Dihydroergotamine—Feeling abnormal—Etoposide—germ cell cancer	0.000587	0.00196	CcSEcCtD
Dihydroergotamine—Nausea—Dactinomycin—germ cell cancer	0.000585	0.00195	CcSEcCtD
Dihydroergotamine—Gastrointestinal pain—Etoposide—germ cell cancer	0.000583	0.00195	CcSEcCtD
Dihydroergotamine—Visual impairment—Methotrexate—germ cell cancer	0.000579	0.00193	CcSEcCtD
Dihydroergotamine—Vomiting—Ifosfamide—germ cell cancer	0.000574	0.00192	CcSEcCtD
Dihydroergotamine—Hypersensitivity—Cisplatin—germ cell cancer	0.000573	0.00191	CcSEcCtD
Dihydroergotamine—Rash—Ifosfamide—germ cell cancer	0.000569	0.0019	CcSEcCtD
Dihydroergotamine—Dermatitis—Ifosfamide—germ cell cancer	0.000568	0.0019	CcSEcCtD
Dihydroergotamine—Urticaria—Etoposide—germ cell cancer	0.000566	0.00189	CcSEcCtD
Dihydroergotamine—Body temperature increased—Etoposide—germ cell cancer	0.000563	0.00188	CcSEcCtD
Dihydroergotamine—Abdominal pain—Etoposide—germ cell cancer	0.000563	0.00188	CcSEcCtD
Dihydroergotamine—Tinnitus—Methotrexate—germ cell cancer	0.00056	0.00187	CcSEcCtD
Dihydroergotamine—Asthenia—Cisplatin—germ cell cancer	0.000558	0.00186	CcSEcCtD
Dihydroergotamine—ABCB1—gonad—germ cell cancer	0.000556	0.00165	CbGeAlD
Dihydroergotamine—ABCB1—uterus—germ cell cancer	0.000552	0.00164	CbGeAlD
Dihydroergotamine—ABCB1—pituitary gland—germ cell cancer	0.000542	0.00161	CbGeAlD
Dihydroergotamine—ADRA2A—brain—germ cell cancer	0.000539	0.0016	CbGeAlD
Dihydroergotamine—Chills—Methotrexate—germ cell cancer	0.000539	0.0018	CcSEcCtD
Dihydroergotamine—Nausea—Ifosfamide—germ cell cancer	0.000536	0.00179	CcSEcCtD
Dihydroergotamine—Diarrhoea—Cisplatin—germ cell cancer	0.000532	0.00178	CcSEcCtD
Dihydroergotamine—Hypersensitivity—Etoposide—germ cell cancer	0.000525	0.00175	CcSEcCtD
Dihydroergotamine—ABCB1—medulla oblongata—germ cell cancer	0.000523	0.00156	CbGeAlD
Dihydroergotamine—ADRA2A—lymph node—germ cell cancer	0.000521	0.00155	CbGeAlD
Dihydroergotamine—Asthenia—Etoposide—germ cell cancer	0.000511	0.00171	CcSEcCtD
Dihydroergotamine—Pruritus—Etoposide—germ cell cancer	0.000504	0.00168	CcSEcCtD
Dihydroergotamine—Vomiting—Cisplatin—germ cell cancer	0.000495	0.00165	CcSEcCtD
Dihydroergotamine—Rash—Cisplatin—germ cell cancer	0.00049	0.00164	CcSEcCtD
Dihydroergotamine—Dermatitis—Cisplatin—germ cell cancer	0.00049	0.00164	CcSEcCtD
Dihydroergotamine—Diarrhoea—Etoposide—germ cell cancer	0.000488	0.00163	CcSEcCtD
Dihydroergotamine—Ill-defined disorder—Methotrexate—germ cell cancer	0.000485	0.00162	CcSEcCtD
Dihydroergotamine—ABCB1—adrenal gland—germ cell cancer	0.000484	0.00144	CbGeAlD
Dihydroergotamine—ABCB1—midbrain—germ cell cancer	0.000478	0.00142	CbGeAlD
Dihydroergotamine—Malaise—Methotrexate—germ cell cancer	0.000472	0.00157	CcSEcCtD
Dihydroergotamine—Dizziness—Etoposide—germ cell cancer	0.000471	0.00157	CcSEcCtD
Dihydroergotamine—Vertigo—Methotrexate—germ cell cancer	0.00047	0.00157	CcSEcCtD
Dihydroergotamine—ABCB1—bone marrow—germ cell cancer	0.000469	0.00139	CbGeAlD
Dihydroergotamine—ABCB1—spinal cord—germ cell cancer	0.000467	0.00139	CbGeAlD
Dihydroergotamine—Nausea—Cisplatin—germ cell cancer	0.000462	0.00154	CcSEcCtD
Dihydroergotamine—Vomiting—Etoposide—germ cell cancer	0.000453	0.00151	CcSEcCtD
Dihydroergotamine—ABCB1—female gonad—germ cell cancer	0.000452	0.00134	CbGeAlD
Dihydroergotamine—Rash—Etoposide—germ cell cancer	0.000449	0.0015	CcSEcCtD
Dihydroergotamine—Dermatitis—Etoposide—germ cell cancer	0.000449	0.0015	CcSEcCtD
Dihydroergotamine—Headache—Etoposide—germ cell cancer	0.000446	0.00149	CcSEcCtD
Dihydroergotamine—Myalgia—Methotrexate—germ cell cancer	0.000445	0.00149	CcSEcCtD
Dihydroergotamine—Arthralgia—Methotrexate—germ cell cancer	0.000445	0.00149	CcSEcCtD
Dihydroergotamine—Discomfort—Methotrexate—germ cell cancer	0.00044	0.00147	CcSEcCtD
Dihydroergotamine—Confusional state—Methotrexate—germ cell cancer	0.00043	0.00144	CcSEcCtD
Dihydroergotamine—Nausea—Etoposide—germ cell cancer	0.000423	0.00141	CcSEcCtD
Dihydroergotamine—ABCB1—endocrine gland—germ cell cancer	0.00042	0.00125	CbGeAlD
Dihydroergotamine—ABCB1—head—germ cell cancer	0.000415	0.00123	CbGeAlD
Dihydroergotamine—Hyperhidrosis—Methotrexate—germ cell cancer	0.000413	0.00138	CcSEcCtD
Dihydroergotamine—Anorexia—Methotrexate—germ cell cancer	0.000407	0.00136	CcSEcCtD
Dihydroergotamine—ABCB1—testis—germ cell cancer	0.000401	0.00119	CbGeAlD
Dihydroergotamine—Hypotension—Methotrexate—germ cell cancer	0.000399	0.00133	CcSEcCtD
Dihydroergotamine—Musculoskeletal discomfort—Methotrexate—germ cell cancer	0.000389	0.0013	CcSEcCtD
Dihydroergotamine—Insomnia—Methotrexate—germ cell cancer	0.000386	0.00129	CcSEcCtD
Dihydroergotamine—Paraesthesia—Methotrexate—germ cell cancer	0.000383	0.00128	CcSEcCtD
Dihydroergotamine—Dyspnoea—Methotrexate—germ cell cancer	0.000381	0.00127	CcSEcCtD
Dihydroergotamine—Somnolence—Methotrexate—germ cell cancer	0.000379	0.00127	CcSEcCtD
Dihydroergotamine—Dyspepsia—Methotrexate—germ cell cancer	0.000376	0.00125	CcSEcCtD
Dihydroergotamine—Decreased appetite—Methotrexate—germ cell cancer	0.000371	0.00124	CcSEcCtD
Dihydroergotamine—ABCB1—cerebellum—germ cell cancer	0.00037	0.0011	CbGeAlD
Dihydroergotamine—Fatigue—Methotrexate—germ cell cancer	0.000368	0.00123	CcSEcCtD
Dihydroergotamine—Pain—Methotrexate—germ cell cancer	0.000365	0.00122	CcSEcCtD
Dihydroergotamine—Feeling abnormal—Methotrexate—germ cell cancer	0.000352	0.00117	CcSEcCtD
Dihydroergotamine—Gastrointestinal pain—Methotrexate—germ cell cancer	0.000349	0.00117	CcSEcCtD
Dihydroergotamine—Urticaria—Methotrexate—germ cell cancer	0.000339	0.00113	CcSEcCtD
Dihydroergotamine—Abdominal pain—Methotrexate—germ cell cancer	0.000337	0.00113	CcSEcCtD
Dihydroergotamine—Body temperature increased—Methotrexate—germ cell cancer	0.000337	0.00113	CcSEcCtD
Dihydroergotamine—Hypersensitivity—Methotrexate—germ cell cancer	0.000315	0.00105	CcSEcCtD
Dihydroergotamine—Asthenia—Methotrexate—germ cell cancer	0.000306	0.00102	CcSEcCtD
Dihydroergotamine—Pruritus—Methotrexate—germ cell cancer	0.000302	0.00101	CcSEcCtD
Dihydroergotamine—ABCB1—brain—germ cell cancer	0.0003	0.000894	CbGeAlD
Dihydroergotamine—Diarrhoea—Methotrexate—germ cell cancer	0.000292	0.000975	CcSEcCtD
Dihydroergotamine—ABCB1—lymph node—germ cell cancer	0.00029	0.000864	CbGeAlD
Dihydroergotamine—Dizziness—Methotrexate—germ cell cancer	0.000282	0.000942	CcSEcCtD
Dihydroergotamine—Vomiting—Methotrexate—germ cell cancer	0.000271	0.000906	CcSEcCtD
Dihydroergotamine—Rash—Methotrexate—germ cell cancer	0.000269	0.000899	CcSEcCtD
Dihydroergotamine—Dermatitis—Methotrexate—germ cell cancer	0.000269	0.000898	CcSEcCtD
Dihydroergotamine—Headache—Methotrexate—germ cell cancer	0.000267	0.000893	CcSEcCtD
Dihydroergotamine—Nausea—Methotrexate—germ cell cancer	0.000254	0.000847	CcSEcCtD
